Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Antares Capital Supports Windjammer Capital Investors’ Acquisition of Advanced Instruments

Antares Capital
Posted on: 10 Nov 16

Antares Capital announced today it is serving as administrative agent, joint lead arranger and joint bookrunner of senior secured credit facilities to support the acquisition of Advanced Instruments by Windjammer Capital Investors.

Founded in 1955 and headquartered in Norwood, MA, Advanced Instruments is a leader in laboratory instrumentation.

“We are pleased to have Antares lead the financing for our investment in Advanced Instruments,” said Daniel Lee, Vice President for Windjammer Capital. “They worked quickly and diligently through approvals and made a sizeable commitment to support the transaction.”

“Advanced Instruments is a long standing market leader and an innovator of high quality laboratory equipment,” said Michael Hynes, managing director for Antares. “We are delighted to support Windjammer and Advanced Instruments as they work together to achieve continued growth.”

About Advanced Instruments

Advanced Instruments is a leading designer, manufacturer and marketer of instrumentation and associated consumables for clinical, pharmaceutical, biotechnology, microbiology and dairy laboratories around the world. Quality, reliability, service and support have been the company’s guiding principles since its founding in 1955. Their innovative application of technology helps healthcare organizations improve the quality of care and industrial companies enhance quality and productivity. For more information, visit www.aicompanies.com

About Windjammer Capital Investors

Windjammer Capital Investors, with offices in Newport Beach, California and Waltham, Massachusetts, is a private investment firm that makes control and non-control investments in leading middle market businesses in partnership with management. Founded in 1990, Windjammer’s institutional funds total roughly $2.0 billion of committed capital. Since its formation, Windjammer has invested $1.5 billion in over 50 companies across a broad range of industries. Windjammer is currently investing out of its $726 million Windjammer Senior Equity Fund IV, which closed in March of 2013. For more information, visit www.windjammercapital.com

About Antares Capital

Antares Capital is a leading provider of financing solutions for middle-market, private equity-backed transactions with offices in Atlanta, Chicago, Los Angeles, New York, Norwalk (Connecticut) and Toronto. Antares has facilitated more than $120 billion in financing over the past five years. Antares was named 2015 Dealmakers of the Year and 2014 Lender of the Year by Mergers & Acquisitions. Visit us at www.antares.com or follow Antares Capital on Twitter at https://www.twitter.com/antarescapital. Antares Capital is a subsidiary of Antares Holdings LP.

View source version on businesswire.com: http://www.businesswire.com/news/home/20161110005934/en/

Business Wire
www.businesswire.com

Last updated on: 10/11/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.